Key facts
- This page summarizes C. Richard Reese's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 May 2023, 14:48.
C. Richard Reese - 15 May 2023 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Reporting relationship
- Director
- Issuer ticker
- CRL
- Reported as of
- 15 May 2023
- Net transaction value
- +$321,049
- SEC form
- 4
- Accepted by SEC
- 17 May 2023, 14:48:48 UTC
- Prior SEC filing
- 13 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ C. Richard Reese
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
C. Richard Reese filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 17 May 2023.
Change
- Previous filing in this sequence was filed on 13 May 2022.
- Current net transaction value: +$321,049.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +664
- Change %
- +1%
- Price
- $0.000000
- Shares after
- 65,099
- Date
- 15 May 2023
- Ownership
- Direct
- Footnotes
- F1
CRL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +442
- Change %
- +0.68%
- Price
- $0.000000
- Shares after
- 65,541
- Date
- 15 May 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRL
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $321,049
- Shares
- +1,669
- Change %
- Price
- $192.36
- Shares after
- 1,669
- Date
- 15 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,669
- Exercise price
- $192.36
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The unvested restricted stock units vest upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders.
Footnote F2
The grant was made in lieu of director service fees for the term commencing May 9, 2023. The restricted stock units vest upon the earlier of 5/15/2023 or the business day prior to the Company's next annual meeting of shareholders.
Footnote F3
The Stock Options become exercisable upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders.